Literature DB >> 33563205

Clinical impact of respiratory syncytial virus infection on children hospitalized for pertussis.

Ruimu Zhang1, Jikui Deng2.   

Abstract

BACKGROUND: Although Respiratory syncytial virus (RSV) is one of the common pathogens in children with pertussis and viral coinfection, the clinical impact of RSV infection on pertussis remains unclear. We compared clinical characteristics and sought differences between infants with single Bordetella pertussis (B. pertussis) infection and those with RSV coinfection.
METHODS: We enrolled 80 patients with pertussis who were hospitalized in Shenzhen Children's Hospital from January 2017 to December 2019. Respiratory tract samples were tested for B. pertussis with real-time polymerase chain reaction and respiratory viruses with immunofluorescence assay. Clinical data were obtained from hospital records and collected using a structured questionnaire.
RESULTS: Thirty-seven of 80 patients had B. pertussis infection alone (pertussis group) and 43 had RSV-pertussis coinfection (coinfection group). No significant differences were found with regard to sex, body weight, preterm birth history, pertussis vaccination, symptoms, presence of pneumonia, or lymphocyte count between the 2 groups. Univariate analysis showed patients with RSV coinfection were older (median, 4.57 months vs 4.03 months, p = 0.048); more commonly treated with β-lactam antibiotics (21% vs 5%, p = 0.044); had higher rates of wheezes (40% vs 14%, p = 0.009) and rales (35% vs 14%, p = 0.028) on chest auscultation, a higher rate of readmission (40% vs 11%, p = 0.004), and a longer hospital stay (median, 10 days vs 7 days, p = 0.002). In the further binary logistic regression analysis, patients with RSV coinfection had higher rates of wheezes (OR = 3.802; 95% CI: 1.106 to 13.072; p = 0.034) and readmission (OR = 5.835; 95% CI: 1.280 to 26.610; p = 0.023).
CONCLUSIONS: RSV coinfection increases readmission rate in children hospitalized for pertussis. RSV infection should be suspected when wheezes are present on auscultation of the chest in these patients. Early detection of RSV may avoid unnecessary antibiotic use.

Entities:  

Keywords:  Children; Pertussis; Respiratory syncytial virus

Mesh:

Substances:

Year:  2021        PMID: 33563205      PMCID: PMC7871314          DOI: 10.1186/s12879-021-05863-9

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  12 in total

1.  On the aetiology of whooping cough.

Authors:  F A Lewis; I D Gust; N M Bennett
Journal:  J Hyg (Lond)       Date:  1973-03

2.  Respiratory failure caused by dual infection with Bordetella pertussis and respiratory syncytial virus.

Authors:  T Aoyama; Y Ide; J Watanabe; Y Takeuchi; A Imaizumi
Journal:  Acta Paediatr Jpn       Date:  1996-06

3.  Rapid testing for respiratory viruses: Impact on antibiotic use and time to patient discharge.

Authors:  Kevin O'Callaghan; Kay Jones
Journal:  Infect Dis Health       Date:  2019-05-31

4.  Pertussis and respiratory syncytial virus infections.

Authors:  Cécile Cosnes-Lambe; Josette Raymond; Martin Chalumeau; Charlotte Pons-Catalano; Florence Moulin; Nathalie de Suremain; Hélène Reglier-Poupet; Pierre Lebon; Claire Poyart; Dominique Gendrel
Journal:  Eur J Pediatr       Date:  2007-11-23       Impact factor: 3.183

5.  Antibiotic Overuse in Children with Respiratory Syncytial Virus Lower Respiratory Tract Infection.

Authors:  Chantal B van Houten; Christiana Naaktgeboren; Brigitte J M Buiteman; Maaike van der Lee; Adi Klein; Isaac Srugo; Irena Chistyakov; Wouter de Waal; Clemens B Meijssen; Pieter W Meijers; Karin M de Winter-de Groot; Tom F W Wolfs; Yael Shachor-Meyouhas; Michal Stein; Elisabeth A M Sanders; Louis J Bont
Journal:  Pediatr Infect Dis J       Date:  2018-11       Impact factor: 2.129

6.  Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection.

Authors: 
Journal:  Pediatrics       Date:  2014-08       Impact factor: 7.124

7.  Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.

Authors:  M Pamela Griffin; Yuan Yuan; Therese Takas; Joseph B Domachowske; Shabir A Madhi; Paolo Manzoni; Eric A F Simões; Mark T Esser; Anis A Khan; Filip Dubovsky; Tonya Villafana; John P DeVincenzo
Journal:  N Engl J Med       Date:  2020-07-30       Impact factor: 176.079

8.  High prevalence of Bordetella pertussis in children under 5 years old hospitalized with acute respiratory infections in Lima, Peru.

Authors:  Ivana Pavic-Espinoza; Sandy Bendezú-Medina; Angella Herrera-Alzamora; Pablo Weilg; María J Pons; Miguel Angel Aguilar-Luis; Verónica Petrozzi-Helasvuo; Juana del Valle Mendoza
Journal:  BMC Infect Dis       Date:  2015-12-02       Impact factor: 3.090

9.  Infants hospitalized for Bordetella pertussis infection commonly have respiratory viral coinfections.

Authors:  A Frassanito; R Nenna; A Nicolai; A Pierangeli; A E Tozzi; P Stefanelli; R Carsetti; C Concato; I Schiavoni; F Midulla
Journal:  BMC Infect Dis       Date:  2017-07-12       Impact factor: 3.090

10.  Bordetella Pertussis Infection in Hospitalized Infants with Acute Bronchiolitis.

Authors:  Şule Gökçe; Zafer Kurugöl; S Şöhret Aydemir; Candan Çiçek; Aslı Aslan; Güldane Koturoğlu
Journal:  Indian J Pediatr       Date:  2017-10-27       Impact factor: 1.967

View more
  1 in total

1.  Impact of the COVID-19 pandemic on Bordetella pertussis infections in England.

Authors:  Elise Tessier; Helen Campbell; Sonia Ribeiro; Yuma Rai; Simon Burton; Partho Roy; Norman K Fry; David Litt; Gayatri Amirthalingam
Journal:  BMC Public Health       Date:  2022-02-28       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.